Hepatic transplantation;La transplantation hépatique

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 8-9, 2009, Pages 868-881

  Duvoux, C ^a   Samuel, D ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; PEGINTERFERON; RIBAVIRIN; TACROLIMUS;

ALCOHOL LIVER CIRRHOSIS; ANESTHESIOLOGICAL TECHNIQUES; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOCYTE DEPLETION; MIXED INFECTION; PRIMARY SCLEROSING CHOLANGITIS; SHORT SURVEY; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 70349182306     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.05.003     Document Type: Short Survey

References (75)

1. Starzl T.E., Marchiodoro T.L., Von Kaulla K.N., Hermann G., Brittain R.S., and Waddell W.R. Homotransplantation of the liver in humans. Surg Gynecol Obstet 117 (1963) 659-676
2. Starzl T.E., Koep L., Porter K.A., Schroter G.P.J., Weil R., Hartley R.B., et al. Decline in survival after liver transplantation. Arch Surg 115 (1980) 815-819
3. National Institutes of Health Consensus Development Conference Statement: Liver transplantation, 1983. Hepatology 1984;4:107S-10S.
4. Bismuth H. L'irrésistible avènement de la transplantation hépatique. Gastroenterol Clin Biol 10 (1986) 789-792
5. European Liver Transplant Registry. Available at: http://www.eltr.org Update 2008.
6. Samuel D., Muller R., Alexander G., Fassati L., Ducot B., Benhamou J.P., et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329 (1993) 1842-1847
7. Terrault N., Roche B., and Samuel D. Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective. Liver Transpl 11 (2005) 716-732
8. Féray C., Gigou M., Samuel D., David M.F., Paradis V., Reynes M., et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 20 (1994) 1137-1143
9. Lucey M.R., Merion R.M., Henley K.S., Campbell Jr. D.A., Turcotte J.G., Nostrant T.T., et al. Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 102 (1992) 1736-1741
10. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., and Dennisson A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218 (1993) 145-151
11. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
12. Bismuth H., Samuel D., Gugenheim J., Castaing D., Bernuau J., Rueff B., et al. Emergency liver transplantation for fulminant hepatitis. Ann Int Med 107 (1987) 337-341
13. Jury of The Conference of Consensus on the Indications of Liver Transplantation. Consensus Statement on Indications for Liver Transplantation: Paris June 22-23, 1993. Hepatology 1994;20:63S-8S.
14. Griffith B.P., Shaw Jr. B.W., Hardesty R.L., Iwatsuki S., Bahnson H.T., and Starzl T.E. Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet 160 (1985) 271-273
15. Bismuth H., and Houssin D. Reduced sized orthotopic liver graft in hepatic transplantation in children. Surgery 95 (1984) 367-370
16. Emond J.C., Whitington P.F., Thistlethwaite J.R., Alonso E.A., and Broelsch C.E. Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology 10 (1989) 867-872
17. Pichlmayr R., Ringe B., Gubernatis G., Hauss J., and Bunzendahl H. Transplantation einer spenderleber auf zwei empfanger (splitting transplantation): eine neue methode in der weiterentwicklung der lebersegmenttransplantation. Langenbecks Arch Chir 373 (1988) 127-130
18. Bismuth H., Morino M., Castaing D., Gillon M.C., Descorps Declere A., et al. Emergency orthotopic liver transplantation in two patients using one donor liver. Br J Surg 76 (1989) 722-724
19. Raia S., Nery J.R., and Mies S. Liver transplantation from live donors. Lancet 2 (1989) 497
20. Strong R.W., Lynch S.V., Ong T.H., Matsunami H., Koido Y., and Balderson G.A. Successful liver transplantation from a living donor to her son. N Engl J Med 322 (1990) 1505-1507
21. Broelsch C.E., Whitington P.F., Emond J.C., Heffron T.G., Thistlethwaite J.R., Stevens L., et al. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg 214 (1991) 428-439
22. The European FK 506 multicentre Study Group. Randomized trial comparing tacrolimus (FK 506) and cyclosporin in prevention of liver allograft rejection. Lancet 344 (1994) 423-428
23. Rapport de l'Agence de la biomédecine 2007. www.agence-biomedecine.fr.
24. Malinchoc M., Kamath P.S., Gordon F.D., Peine C.J., Rank J., and Ter Borg P.C. A model to predict poor survival in patients undergoing intrahepatic portosystemic shunts. Hepatology 31 (2000) 864-871
25. Roche B., and Samuel D. Risk factors for hepatitis C recurrence after liver transplantation. J Viral Hepat 14 (2007) 89-96
26. Berenguer M., Prieto M., Rayón J.M., Mora J., Pastor M., Ortiz V., et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 32 (2000) 852-858
27. Carrión J.A., Navasa M., García-Retortillo M., García-Pagan J.C., Crespo G., Bruguera M., et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 132 (2007) 1746-1756
28. Samuel D., Weber R., Stock P., Duclos-Vallée J.C., and Terrault N. Are HIV-infected patients candidates for liver transplantation?. J Hepatol 48 (2008) 697-707
29. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 Suppl. 1 (2004) S27-34
30. UNOS registry. www.unos.org.
31. CEC, Action plan on Organ Donation and Transplantation (2009-2015): Strengthened Cooperation between Member States, Brussel 8.12. 2008.
32. Casavilla A., Ramirez C., Shapiro R., Nghiem D., Miracle K., Bronsther O., et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 59 (1995) 197-203
33. Suarez F., Otero A., Solla M., Arnal F., Lorenzo M.J., Marini M., et al. Biliary complications after liver transplantation from Maastricht category-2 non-heart-beating donors. Transplantation 85 (2008) 9-14
34. Abt P.L., Desai N.M., Crawford M.D., Forman L.M., Markmann J.W., Olthoff K.M., et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 239 (2004) 87-92
35. Reddy S., Zilvetti M., Brockmann J., McLaren A., and Friend P. Liver transplantation from non-heart-beating donors: current status and future prospects. Liver Transpl 10 (2004) 1223-1232
36. Durand F., Renz J.F., Alkofer B., Burra P., Clavien P.A., Porte R.J., et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl 14 (2008) 1694-1707
37. Feng S., Goodrich N.P., Bragg-Gresham J.L., Dykstra D.M., Punch J.D., DebRoy M.A., et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6 (2006) 783-790
38. Müllhaupt B., Dimitroulis D., Gerlach J.T., and Clavien P.A. Hot topics in liver transplantation: organ allocation-extended criteria donor-living donor liver transplantation. J Hepatol 48 Suppl. 1 (2008) S58-67
39. Rana A., Hardy M.A., Halazun K.J., Woodland D.C., Ratner L.E., Samstein B., et al. Survival outcomes following liver transplant (SOFT) score: a novel method to predict patient survival post-transplant. Am J Transplant 12 (2008) 2537-2546
40. Sampietro R., Goffette P., Danse E., De Reyck C., Roggen F., Ciccarelli O., et al. Extension of the adult hepatic allograft pool using split liver transplantation. Acta Gastroenterol Belg 68 (2005) 369-375
41. Bilan des activités de prélèvement et de greffe en France en 2007. Tableau F12, Page 93, http://www.agence-biomedecine.fr/annexes/bilan2007/pdf/synthese_greffe.p df [consulté en 2009].
42. Bilan des activités de prélèvement et de greffe en France en 2007. Tableau F13, Page 94, http://www.agence-biomedecine.fr/annexes/bilan2007/pdf/synthese_greffe.p df [consulté en 2009].
43. Patel S., Orloff M., Tsoulfas G., Kashyap R., Jain A., Bozorgzadeh A., et al. Living-donor liver transplantation in the United States: identifying donors at risk for perioperative complications. Am J Transplant 7 (2007) 2344-2349
44. Berg C.L., Gillespie B.W., Merion R.M., Brown Jr. R.S., Abecassis M.M., Trotter J.F., et al. Improvement in survival associated with adult-to-adults living donor liver transplantation. Gastroenterology 133 (2007) 1806-1813
45. Marcos A., Fisher R.A., Ham J.M., Olzinski A.T., Shiffman M.L., Sanyal A.J., et al. Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation 69 (2000) 2410-2415
46. Tan H.P., Patel-Tom K., and Marcos A. Adult living donor liver transplantation: who is the ideal donor and recipient?. J Hepatol 43 (2005) 13-17
47. Merion R.M., Schaubel D.E., Dykstra D.M., Freeman R.B., Port F.K., and Wolfe R.A. The survival benefit of liver transplantation. Am J Transplant 5 (2005) 307-313
48. Poynard T., Naveau S., Doffoël M., Boudjema K., Vanlemmens C., Mantion G., et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group. Hepatol 30 (1999) 1130-1137
49. Vanlemmens C., Di Martino V., Milan C., Messner M., Minello A., Duvoux C., et al. Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial. Ann Intern Med 150 (2009) 153-161
50. Majno P.E., Sarasin F.P., Mentha G., and Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 31 (2000) 899-906
51. Bryant R., Laurent A., Tayar C., van Nhieu J.T., Luciani A., and Cherqui D. Liver resection for hepatocellular carcinoma. Surg Oncol Clin N Am 17 (2008) 607-633
52. Dvorchik I., Schwartz M., Fiel M.I., Finkelstein S.D., and Marsh J. Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma. Liver Transpl 14 (2008) 43-50
53. Freeman R.B., Wiesner R.H., Edwards E., Harper A., Merion R., Wolfe R., and United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 10 (2004) 7-15
54. Kim W.R., Biggins S.W., Kremers W.K., Wiesner R.H., Kamath P.S., Benson J.T., et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359 (2008) 1018-1026
55. Jain A., Demetris A.J., Kashyap R., Blakomer K., Ruppert K., Khan A., et al. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl 7 (2001) 623-630
56. Ojo A.O., Held P.J., Port F.K., Wolfe R.A., Leichtman A.B., Young E.W., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931
57. Duvoux C. Long-term management of liver transplant recipients: metabolic complications. In: Berenguer (Ed). Liver transplantation for the non specialist (2007), Permanyer Publications, Barcelona
58. Haagsma E.B., Hagens V.E., Schaapveld M., van den Berg A.P., de Vries E.G., Klompmaker I.J., et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34 (2001) 84-91
59. Mazariegos G.V., Reyes J., Marino I.R., Demetris A.J., Flynn B., Irish W., et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 63 (1997) 243-249
60. Mazariegos G.V., Sindhi R., Thomson A.W., and Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transplant Immunol 17 (2007) 114-119
61. Calne R.Y. Prope tolerance- the future of organ transplantation from the laboratory to the clinic. Transpl Immunol 13 (2004) 83-86
62. Cortesini R., and Suciu-Foca N. The concept of "partial" clinical tolerance. Transpl Immunol 13 (2004) 101-104
63. Martínez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 118 (2008) 2845-2857
64. Demirkiran A., Hendrikx T.K., Baan C.C., and van der Laan L.J. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?. Transplantation 85 (2008) 783-789
65. Calne R., Friend P., Moffatt S., Bradley A., Hale G., Firth J., et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 351 (1998) 1701-1702
66. Swanson S.J., Hale D.A., Mannon R.B., Kleiner D.E., Cendales L.C., Chamberlain C.E., et al. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 360 (2002) 1662-1664
67. Battaglia M., Stabilini A., and Roncarolo M.G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105 (2005) 4743-4748
68. Larsen C.P., Knechtle S.J., Adams A., Pearson T., and Kirk A.D. A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression. Am J Transplant 6 (2006) 876-883
69. Vincenti F., Larsen C., Durrbach A., Wekerle T., Nashan B., Blancho G., et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353 (2005) 770-781
70. Farkas S.A., Schnitzbauer A.A., Kirchner G., Obed A., Banas B., and Schlitt H.J. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 22 (2009) 49-60
71. Pageaux G.P., Rostaing L., Calmus Y., Duvoux C., Vanlemmens C., Hardgwissen J., et al. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl 12 (2006) 1755-1760
72. Forns X., García-Retortillo M., Serrano T., Feliu A., Suarez F., de la Mata M., et al. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol 39 (2003) 389-396
73. Berenguer M. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol 49 (2008) 274-287
74. Hudes G., Carducci M., Tomczak P., Dutcher J., Figlin R., Kapoor A., et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356 (2007) 2271-2281
75. Decaens T, Duvoux C. Carcinome hépatocellulaire et transplantation hépatique : rôle futur des inhibiteurs de m-TOR. Gastroenterol Clin Biol (in press).